Yanan He

ORCID: 0000-0002-0756-4306 · 12 papers in corpus · active 2017-2025

Study types

  • article 7
  • other 3
  • preprint 2

Condition tags

  • endometriosis 12
  • mesh:D004715 6
  • infertility 3
  • dyspareunia 1
other 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1748838

[This corrects the article DOI: 10.3389/fimmu.2023.1115504.].

other 2025
International journal of women's health ·doi:10.2147/IJWH.S552629

BACKGROUND: Endometriosis (EMs) is a benign gynecological disorder that exhibits several malignant characteristics, including proliferation and angiogenesis. N6-methyladenosine (m6A) modification plays a crucial role in regulating RNA splic…

preprint 2024
·doi:10.21203/rs.3.rs-4509482/v1

Abstract Background: N6-methyladenosine(m6A) modification regulates the processes of RNA splicing, subcellular localization, translation and stability by changing the RNA structure and the interaction between RNA and RNA-binding proteins to…

preprint 2023
·doi:10.21203/rs.3.rs-3003927/v1

Abstract Background N6-methyladenosine(m6A) modification regulates the processes of RNA splicing, subcellular localization, translation and stability by changing the RNA structure and the interaction between RNA and RNA-binding proteins to …

article 2023
Journal of immunology research ·doi:10.1155/2023/2975581

Background. Endometriosis is an inflammatory gynecological disease leading to deep pelvic pain, dyspareunia, and infertility. The pathophysiology of endometriosis is complex and depends on a variety of biological processes and pathways. The…

article 2023
Frontiers in immunology ·doi:10.3389/fimmu.2023.1115504

Background: Endometriosis (EM) is a benign, multifactorial, immune-mediated inflammatory disease that is characterized by persistent activation of the NF-κB signaling pathway and some features of malignancies, such as proliferation and lymp…

article 2022
BMC molecular and cell biology ·doi:10.1186/s12860-022-00426-5

BACKGROUND: Endometriosis is one of the most common gynecological diseases, and seriously reduces the quality of life of patients. However, the pathogenesis of this disease is unclear. Therefore, more studies are needed to elucidate its pat…

article 2022
Epigenomics ·doi:10.2217/epi-2022-0249

Aim: To identify epigenetic alterations of differentially expressed genes and screen out targeted therapeutic drugs in endometriosis. Methods: Based on the Gene Expression Omnibus database and a series of biological information analysis too…

other 2021
Frontiers in molecular biosciences ·doi:10.3389/fmolb.2021.743012

Background: Endometriosis is a serious gynecological disorder characterized by debilitating pain, infertility and the establishment of innervated endometriosis lesions outside the uterus. Early detection and accurate diagnosis are pivotal i…

article 2020
Stem cell research & therapy ·doi:10.1186/s13287-020-01856-8

BACKGROUND: Research into the pathogenesis of endometriosis (EMs) would substantially promote its effective treatment and early diagnosis. However, the aetiology of EMs is poorly understood and controversial despite the progress in EMs rese…

article 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.02.138
article 2017
Stem cells international ·doi:10.1155/2017/4794827

Human endometrial tissue has become an attractive source of mesenchymal stem cells (MSCs) for cell-based therapies because these MSCs can be easily harvested and have tumour tropism as well as reduced immunogenic and inflammatory properties…